Agenovir agenovir.com


Public list: Smart Money VCs (6327) Pharma Startups (4733)

Agenovir is a player in the research and development of a novel class of human therapeutics to address diseases associated with or caused by latent or persistent viral reservoirs. The individuals affected by these diseases number in the millions, and treatment options are extremely limited or non-existent. Using virology expertise and targeted genome editing technologies, Agenovir's mission is to develop innovative treatments that disrupt or eliminate pathogenic viral genomes, bringing hope to p...Show all

Agenovir is a player in the research and development of a novel class of human therapeutics to address diseases associated with or caused by latent or persistent viral reservoirs. The individuals affected by these diseases number in the millions, and...Show all

Company (Acquired)

Phone: 650-491-9624

Fax:

499 Illinois Street
Suite 500
San Francisco, 94158
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Agenovir $10.6M May 9, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Agenovir Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Antiviral nuclease methods Feb 24, 2017 Application
Oncoviral treatment with nuclease and chemotherapeutic Feb 24, 2017 Application
Antiviral treatment with low immunogenicity Feb 24, 2017 Application
Transgenic nuclease systems and methods Sep 28, 2016 Application
Compositions and methods for treatment of latent viral infections Sep 27, 2016 Application
See all 15 patents